卖什么
多组学+AI4S研发，全球布局。
商业模式拆解
买家：谁掌握预算？
未核实Principal investigators and core facilities at universities, institutes and hospitals; biopharma QC/analytics teams.
触发点：什么让他们现在购买？
Need omics data (metabolomics, proteomics, transcriptomics) and biologic characterization without owning mass-spec infrastructure.
工作流：什么输入变成什么输出？
Submit samples; service lab runs untargeted/targeted metabolomics, lipidomics, proteomics, PTMs, single-cell/spatial omics, sequencing and multi-omics, plus biologics characterization (structure, purity, glycosylation, affinity, cell activity); delivers data and analysis.
经济账：省了什么，怎么收费？
未核实Per-sample, per-project service fees; also sells LIMS and automated sample-prep instruments (Qlab3).
渠道：怎么接触到客户？
Direct sales through group sub-sites (Biotree Tech, Pharma, Overseas, Medical, Information) and online ordering/contact.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-10-10 | B 轮 | 近亿元 | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.